Author(s): Jang SY, Choi KS, Lee SJ
Abstract Share this page
Abstract Intravitreal injection of bevacizumab has been shown to satisfactorily treat retinopathy of prematurity; nevertheless, the safety of antivascular endothelial growth factor therapy in children remains uncertain. We report a patient with bilateral, zone 1, stage 3 plus retinopathy of prematurity who was treated with combined laser photocoagulation and intravitreal ranibizumab injection and demonstrated full regression at 3 months after injection but then developed bilateral retinal detachments 1 month later. Copyright © 2010. Published by Mosby, Inc.
This article was published in J AAPOS
and referenced in Journal of Steroids & Hormonal Science